News for Orexo AB (C5G.BE)

/PRNewswire/ -- Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY) today announces the company will collaborate with ApexB.io and Magellan Rx Management to further...

Orexo AB (publ.), (

UPPSALA, Sweden, Feb. 4, 2021 /PRNewswire/ -- Orexo AB (publ.), ('Orexo' or the 'Company') (STO:ORX) (OTCQX:ORXOY) has successfully issued senior ...

/PRNewswire/ -- Orexo AB (publ.), ("Orexo" or the "Company") (STO: ORX) (OTCQX: ORXOY) has mandated ABG Sundal Collier AB to arrange a series of fixed income...

Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY) today announces that the company has further strengthened the intellectual property (IP) for its flagship pharmaceutical pipeline asset OX124, a naloxone rescue medication for the treatment of opioid overdose. The US Patent and Trademark Office (USPTO) has issued a new patent protecting the product until 2039.

Pune, India, Jan. 13, 2021 (GLOBE NEWSWIRE) -- The global opioid use disorder market is expected to experience exponential growth by reaching USD 4.87 ...